SEC Form 4 · accession 0001179110-16-032500
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Schoeneck
Officer — President and CEO · Director
Period of report
Dec 1, 2016
Accepted (ET)
Dec 6, 2016 · 6:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Dec 1, 2016 | F | 66,793 | $18.55 | D | 61,207 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of restricted stock forfeited to meet the tax liability triggered by the vesting of such restricted stock.
- F2Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person.
- F3Amount does not include 433,898 shares of common stock held indirectly by family trust.